EUVIMEDEUVIMED entdecken
Crossref

E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway

Huan Liu, Ning Wang, Run Yang, Jing Luan, Meng Cao, Cui Zhai, Shan Wang, Mengqian Wei, Duorong Wang, Jiayue Qiao, Yuqian Liu, Wenting She und 3 weitere

Journal of Investigative Dermatology · 2024

DOI: 10.1016/j.jid.2024.03.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Huan Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China; Shaanxi Provincial Key Laboratory of Brain Diseases, Xi'an Med…. Hauptthemen laut MEDLINE: Carcinogenesis, Carcinoma, Squamous Cell, Cytokine Receptor gp130, Interleukin-6. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Shaanxi Province Department of Science and Technology, National Natural Science Foundation of China, Education Department of Shaanxi Provincial government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-6 signaling plays a crucial role in the survival and metastasis of skin cancer. NEDD4L acts as a suppressor of IL-6 signaling by targeting GP130 degradation. However, the effects of the NEDD4L-regulated IL-6/GP130 signaling pathway on skin cancer remain unclear. In this study, protein expression levels of NEDD4L and GP130 were measured in tumor tissues from patients with cutaneous squamous cell carcinoma. Skin tumors were induced in wild-type and Nedd4l-knockout mice, and activation of the IL-6/GP130/signal transducer and activator of transcription 3 signaling pathway was detected. The results indicated a negative correlation between the protein expression levels of NEDD4L and GP130 in cutaneous squamous cell carcinoma tissues from patients. Nedd4l deficiency significantly promoted 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin tumorigenesis and benign-to-malignant conversion by activating the IL-6/GP130/signal transducer and activator of transcription 3 signaling pathway, which was abrogated by supplementation with the GP130 inhibitor SC144. Furthermore, our findings suggested that NEDD4L can interact with GP130 and promote its ubiquitination in skin tumors. In conclusion, our results indicate that NEDD4L could act as a tumor suppressor in skin cancer, and inhibition of GP130 could be a potential therapeutic method for treating this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogenesisCarcinoma, Squamous CellCytokine Receptor gp130Interleukin-6Nedd4 Ubiquitin Protein LigasesSignal TransductionSkin NeoplasmsAnimalsFemaleHumansMaleMiceGene Expression Regulation, NeoplasticMice, KnockoutSTAT3 Transcription FactorUbiquitin-Protein Ligases

Stichwörter der Autor:innen

GP130NEDD4LSC144Skin cancerUbiquitination

Substanzen

Cytokine Receptor gp130IL6 protein, humanInterleukin-6Nedd4 Ubiquitin Protein LigasesNedd4L protein, humanNedd4l protein, mouseSTAT3 Transcription FactorUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China; Shaanxi Provincial Key Laboratory of Brain Diseases, Xi'an Medical University, Xi'an, China.
  • Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, China.
  • School of Clinical Medicine, Xi'an Medical University, Xi'an, China.
  • College of pharmacy, Xi'an Medical University, Xi'an, China.
  • Department of Immunology, Xi'an Medical University, Xi'an, China.
  • Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an, China. Electronic address: liaobo@fmmu.edu.cn.

Förderung

  • Shaanxi Province Department of Science and Technology
  • National Natural Science Foundation of China
  • Education Department of Shaanxi Provincial government

Zitieren

APA

Liu, H., Wang, N., Yang, R., Luan, J., Cao, M., Zhai, C., Wang, S., Wei, M., Wang, D., Qiao, J., Liu, Y., She, W., Guo, N., Liao, B., & Gou, X. (2024). E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.03.030

Vancouver

Liu H, Wang N, Yang R, Luan J, Cao M, Zhai C, et al. E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.03.030

BibTeX
@article{Liu2024,
  author = {Liu, Huan and Wang, Ning and Yang, Run and Luan, Jing and Cao, Meng and Zhai, Cui and Wang, Shan and Wei, Mengqian and Wang, Duorong and Qiao, Jiayue and Liu, Yuqian and She, Wenting and Guo, Na and Liao, Bo and Gou, Xingchun},
  title = {E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway},
  journal = {Journal of Investigative Dermatology},
  year = {2024},
  doi = {10.1016/j.jid.2024.03.030}
}
Kostenlos starten →